Increased release of NO during ischemia reduces myocardial contractility and improves metabolic dysfunction

Circulation

Volumn 93, Issue 2, 1996, Pages 356-364

  Node, Koichi ^a   Kitakaze, Masafumi ^a   Kosaka, Hiroaki ^a   Komamura, Kazuo ^a   Minamino, Tetsuo ^a   Inoue, Michitoshi ^a   Tada, Michihiko ^a   Hori, Masatsugu ^a   Kamada, Takenobu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

ischemia; L NAME; myocardial contraction; nitric oxide; receptors, adrenergic

Indexed keywords

ARGININE; CALCIUM CHLORIDE; ISOPRENALINE; LACTIC ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OXIDOPAMINE; PHENTOLAMINE; PROPRANOLOL;

ANAEROBIC METABOLISM; ANIMAL EXPERIMENT; ARTICLE; BETA ADRENERGIC STIMULATION; BLOOD PH; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY HEMODYNAMICS; DOG; DOSE RESPONSE; HEART DENERVATION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; INOTROPISM; INTRACORONARY INFUSION; INTRAVENOUS DRUG ADMINISTRATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL;

EID: 0030031216     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.2.356     Document Type: Article

References (60)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
2. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-527.
3. Shah AM, Lewis MJ. Modulation of myocardial contraction by endocardial and coronary vascular endothelium. Trends Cardiovasc Med. 1993;3:98-103.
4. Ramacioti C, Sharkey A, McClellan G, Winegrad S. Endothelial cells regulate cardiac contractility. Proc Natl Acad Sci USA. 1992; 89:33-36.
5. Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci USA. 1993;90:347-351.
6. 2+ in intact cardiac myocytes. Circ Res. 1994;74:970-978.
7. Nawrath H. Does cyclic GMP mediate the negative inotropic effect of acetylcholine in the heart? Nature. 1977;267:72-74.
8. Brady AJB, Poole-Wilson PA, Harding SE, Warren JB. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol. 1992;263:H1963-H1966.
9. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol. 1993;265:H176-H186.
10. Suffredini AF, Fromm RE, Parker MM. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med. 1989;321:2807-2810.
11. Sobotka PA, McMannis J, Fisher RI, Stein DG, Thomas J. Effects of interleukin 2 on cardiac function in the isolated rat heart. J Clin Invest. 1990;86:845-850.
12. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992;257:387-389.
13. Shah AM, Evans HG, Lewis MJ. Interleukin-1β mimics the characteristic effect of endothelium-derived relaxing factor (EDRF) on myocardial contraction. J Vasc Res. 1992;29:195-198.
14. Knowles RG, Salter M, Brooks SL, Moncada S. Anti-inflammatory glucocorticoids inhibit the induction of nitric oxide synthase by endotoxin in the rat. Biochem J. 1990;270:833-836.
15. Kitakaze M, Node K, Komamura K, Minamino T, Inoue M, Hori M, Kamada T. Evidence for nitric oxide generation in cardiomyocytes: its augmentation by hypoxia. J Mol Cell Cardiol. 1995;27: 2149-2154.
16. Node K, Kitakaze M, Kosaka H, Komamura K, Minamino T, Tada M, Inoue M, Hori M, Kamada T. Plasma nitric oxide end products are increased in the ischemic canine heart. Biochem Biophys Res Commun. 1995;211:370-374.
17. Balligand JL, Ungureanu D, Kell RA, Kobzik L, Pimental D, Michel T, Smith TW. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest. 1993;91:2314-2319.
18. Miloslav M, Schrader J. Role of nitric oxide in reactive hyperemia of the guinea pig heart. Circ Res. 1992;70:208-212.
19. Park HA, Rubin LE, Gross RS, Levi R. Nitric oxide is a mediator of hypoxic coronary vasodilatation. Circ Res. 1992;71:992-1001.
20. Zweier JL, Wang P, Kuppusamy P. Direct measurement of nitric oxide generation in the ischemic heart using electron paramagnetic resonance spectroscopy. J Biol Chem. 1995;270:304-307.
21. 2-adrenoceptor activity on ischemic myocardium during coronary hypoperfusion in dogs. Circ Res. 1989;65:1632-1645.
22. Mori H, Haruyama S, Shinozaki Y, Okino H, Iida A, Takanashi R, Sakura I, Husseini W, Payne B, Hoffman JIE. New nonradioactive microspheres and more sensitive x-ray fluorescence to measure regional blood flow. Am J Physiol. 1992;263:H1946-H1957.
23. Archie JP, Fixier DE, Ulyot DJ, Hoffman JIE, Utler JR, Carlson EL. Measurement of cardiac output with an organ trapping of radioactive microspheres. J Appl Physiol. 1973;35:148-154.
24. Green LC, Tannenbaum SR, Goldman P. Nitrate synthesis in the germfree and conventional rat. Science. 1991;212:56-58.
25. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and [15N]nitrate in biological fluids. Anal Biochem. 1982;126:131-138.
26. Kosaka H, Tsuda M, Kurashima Y, Esumi H, Terada N, Ito Y, Uozumi M. Marked nitration by stimulation with lipopolysaccharide in ascorbic acid-deficient rats. Carcinogenesis. 1990;11: 1887-1889.
27. Kosaka H, Sakaguchi H, Sawai Y, Kumura E, Seiyama A, Sheng-Song C, Shiga T. Effect of interferon-γ on nitric oxide and hemoglobin production in endotoxin-treated rats and its synergism with interleukin 1 or tumor necrosis factor. Life Sci. 1994;54: 1523-1529.
28. Sato H, Inoue M, Matsuyama T, Ozaki H, Shimazu T, Takeda H, Ishida Y, Kamada T. Hemodynamic effects of the β1-adrenoceptor partial agonist xamoterol in relation to plasma norepinephrine levels during exercise in patients with left ventricular dysfunction. Circulation. 1989;75:213-220.
29. Winer BJ. Statistical Principles in Experimental Design. 2nd ed. New York, NY: Mcgraw-Hill; 1982.
30. Snedecor GW, Cochran WG. Statistical Methods. 6th ed. Ames, Iowa: Iowa State University Press; 1972:258-298.
31. G-Methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo: a role for nitric oxide in the central regulation of sympathetic tone? Circ Res. 1992; 70:607-611.
32. Sneddon JM, Vane JR. Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. Proc Natl Acad Sci USA. 1988;85:2800-2804.
33. Mollace V, Salnemini D, Anggard E, Vane J. Nitric oxide from vascular smooth muscle cells: regulation of platelet reactivity and smooth muscle cell guanylate cyclase. Br J Pharmacol. 1991;104: 633-638.
34. Graaf JC, Banga JD, Moncada S, Palmer RMJ, Groot PG, Sixma JJ. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circulation. 1992;85:2284-2290.
35. Komamura K, Node K, Kosaka H, Inoue M. Endogenous nitric oxide inhibits microthromboembolism in the ischemic heart. Circulation. 1994;90(suppl I):I-345. Abstract.
36. Ma XL, Weyrich AS, Lefer DJ, Lefer AM. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res. 1993;72: 403-412.
37. Wright CD, Mulsch A, Busse R, Osswald H. Generation of nitric oxide by human neutrophils. Biochem Biophys Res Commun. 1989; 160:813-819.
38. G-Nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res. 1993;72: 387-395.
39. 2+ current: involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem. 1993;268:26286-26295.
40. Finkel MS, Oddis CV, Mayer H, Hattler BG, Simmons RL. Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship. J Pharmacol Exp Ther. 1995;272:942-952.
41. Konno Y, Hirata K, Imai T, Marumo F. Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells. Hypertension. 1993;22:34-39.
42. Ljusegren ME, Axelsson KL. Lactate accumulation in isolated hypoxic rat ventricular myocardium: effect of different modulators of the cyclic GMP system. Pharmacol Toxicol. 1993;72:56-60.
43. Beitner R, Haberman S, Cycowitz T. The effect of cyclic GMP on phosphofructokinase from rat tissues. Biochim Biophys Acta. 1977; 482:330-340.
44. Elsner D, Muntze A, Kromer EP, Riegger GAJ. Systemic vasoconstriction induced by inhibition of nitric oxide synthesis is attenuated in conscious dogs with heart failure. Cardiovasc Res. 1991;25: 438-440.
45. G-nitro-L-arginine methyl ester in conscious, Long Evans rats. Br J Pharmacol. 1990;101:625-631.
46. Kelm M, Schrader J. Control of coronary vascular tone by nitric oxide. Circ Res. 1990;66:1561-1575.
47. Ueeda M, Silvia SK, Olsson RA. Nitric oxide modulates coronary autoregulation in the guinea pig. Circ Res. 1992;70:1296-1303.
48. Weyrich AS, Ma XL, Buerke M, Murohara T, Armstead VE, Lefer AM, Nicolas JM, Thomas AP, Lefer DJ, Johansen JV. Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ Res. 1994;75: 692-700.
49. Henning RJ, Khalil IR, Levy MN. Vagal stimulation attenuates sympathetic enhancement of left ventricular function. Am J Physiol. 1990;258:H1470-H1475.
50. Vatner SF, Rutherford JS, Ochs HR. Baroreflex and vagal mechanisms modulating left ventricular contractile responses to sympathetic amines in conscious dogs. Circ Res. 1979;44:195-207.
51. Fujii AM, Vatner SF. Autonomic mechanisms regulating myocardial contractility in conscious animals. Pharmacol Ther. 1985;29: 221-238.
52. Landzberg JS, Parker JD, Gauthier DF, Colucci WS. Effects of intracoronary acetylcholine and atropine on basal and dobutamine-stimulated left ventricular contractility. Circulation. 1994;89: 164-168.
53. Paulus WJ, Vantrimpont PJ, Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans: assessment by bicoronary sodium nitroprusside infusion. Circulation. 1994;89:2070-2078.
54. Hare JM, Keaney JF, Balligand JL, Loscalzo J, Smith TW. Role of nitric oxide in parasympathetic modulation of β-adrenergic myocardial contractility in normal dogs. J Clin Invest. 1995;95:360-366.
55. Hasebe N, Shen YT, Vatner SF. Inhibition of endothelium-derived relaxing factor enhances myocardial stunning in conscious dogs. Circulation. 1993;64:1101-1107.
56. Lefer DJ, Nakanishi K, Johnston WE, Vinten-Johansen J. Antineutrophil and myocardial protecting action of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation. 1993;88:2337-2350.
57. Linz W, Martorana PA, Scholkens BA. Local inhibition of bradykinin degradation in ischemic hearts. J Cardiovasc Pharmacol. 1990;15:S99-S109.
58. Martorana PA, Kettenbach B, Breipohl H, Linz W, Scholkens BA. Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist. Eur J Pharmacol. 1990;182:395-396.
59. Kitakaze M, Minamino T, Node K, Komamura K, Shimozaki Y, Mori H, Kosaka H, Inoue M, Hori M, Kamada T. Beneficial effects of inhibition of angiotensin-converting enzyme on ischemic myocardium during coronary hypoperfusion in dogs. Circulation. 1995; 92:950-961.
60. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 1990;87:1620-1624.